This is a competing renewal application for a postdoctoral T32 training grant in laboratory-based transplantation biology. Solid organ transplantation is the ideal therapy for end stage failure due to kidney, heart, liver, and lung, disease, among other organs. Despite significant improvements in the care of all solid organ transplant recipients long term allograft survival remains suboptimal. Analogously, bone marrow transplantation is an effective therapy for hematologic malignancies, but acute (and chronic) graft versus host disease occurs commonly and causes significant morbidity. Moreover, while scientific progress has increased knowledge, the causes of graft loss (and GVHD) are only partially understood, reliable tolerance induction protocols remain elusive, and the ability to translate what information is available into useful diagnostic, preventive and treatment modalities in patients has been limited. To continue to improve transplant outcomes in humans and as a consequence, improve the long term health of all transplant recipients, research in transplantation must remain cutting edge, and the next generation of physicians/scientists must have the appropriate knowledge base and skills to continue to drive the field forward. Because transplantation is a cross disciplinary field involving multiple medical, surgical, and basic pathology/immunology themes, we believe an effective training environment must be cross-disciplinary. Thus, the objective of this training program is to use an interactive, collaborative, cross-disciplinary approach to train talented young physician-scientists (MD and MD PhD) or PhD-scientists for a successful career in laboratory based, investigative, transplantation immunobiology research. In support of the renewal application, the initial funding period of this training program has been successful in accomplishing the key aim of fostering the careers of trainees in transplantation, in particular, underrepresented minorities. Our rationales for submitting this competitive renewal grant application include: 1) the continued need for improving outcomes following solid organ or hematopoietic cell transplantation, 2) our strong desire to continue to have an impact on the education of future investigators in the field of transplantation, and 3) our belief that the proposed group of trainers will offer diverse basic and translational scientific opportunities within the field of transplantation supported by an established infrastructure designed for training and nurturing young transplant researchers toward independence. We have a diverse and well funded faculty with an interest in transplantation and a strong pool of trainees that includes significant numbers of underrepresented minorities. The program is overseen by P Heeger, who is well recognized and accomplished clinical and basic physician scientist with significant postdoctoral training, and educational, experience. The program is designed to support laboratory based training by individual mentors performing research in transplantation medicine/biology. The cross disciplinary program is supplemented with significant didactic training in transplantation science, grant writing, manuscript preparation and career development so as to optimize the development of independent academic researchers in the transplant field.

Public Health Relevance

In order to continue to improve clinical outcomes following organ transplantation there is an ongoing need to train physicians and scientists who will move the field of transplantation forward. This proposed training program will draw MD, PhD and MD/PhD candidates into a comprehensive training environment to teach them cutting edge science in the transplantation field so as to meet this need. The program is directly relevant to public health in that its goal is to train the next generation of leaders in transplantation medicie and science and thus be able to prolong the survival and function of transplanted organs and improve patient health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI078892-07
Application #
8662683
Study Section
Transplantation Biology &Immunology-2 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
2008-08-01
Project End
2018-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
7
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Fribourg, M; Ni, J; Nina Papavasiliou, F et al. (2018) Allospecific Memory B Cell Responses Are Dependent on Autophagy. Am J Transplant 18:102-112
A Verghese, Divya; Demir, Markus; Chun, Nicholas et al. (2018) T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival. J Immunol 200:2186-2198
Cravedi, Paolo (2017) Rituximab in Membranous Nephropathy: Not All Studies Are Created Equal. Nephron 135:46-50
Fribourg, Miguel; Logothetis, Diomedes E; González-Maeso, Javier et al. (2017) Elucidation of molecular kinetic schemes from macroscopic traces using system identification. PLoS Comput Biol 13:e1005376
Bestard, Oriol; Cravedi, Paolo (2017) Monitoring alloimmune response in kidney transplantation. J Nephrol 30:187-200
Gandolfini, Ilaria; Harris, Cynthia; Abecassis, Michael et al. (2017) Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation. Kidney Int Rep 2:1186-1193
Chun, N; Fairchild, R L; Li, Y et al. (2017) Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection. Am J Transplant 17:2810-2819
Ruggenenti, Piero; Cravedi, Paolo; Chianca, Antonietta et al. (2017) Achieving remission of proteinuria in childhood CKD. Pediatr Nephrol 32:321-330
Crespo, Elena; Cravedi, Paolo; Martorell, Jaume et al. (2017) Posttransplant peripheral blood donor-specific interferon-? enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. Kidney Int 92:201-213
Angeletti, Andrea; Baraldi, Olga; Chiocchini, Anna Laura et al. (2017) Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature. J Clin Case Rep 7:

Showing the most recent 10 out of 38 publications